111 related articles for article (PubMed ID: 22235079)
21. The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with Acute Respiratory Distress Syndrome: A Clinical Review.
García de Acilu M; Leal S; Caralt B; Roca O; Sabater J; Masclans JR
Biomed Res Int; 2015; 2015():653750. PubMed ID: 26339627
[TBL] [Abstract][Full Text] [Related]
22. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.
Pontes-Arruda A; Aragão AM; Albuquerque JD
Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002
[TBL] [Abstract][Full Text] [Related]
23. Enteral therapy to decrease morbidity and improve survival in acute respiratory distress syndrome: its time has come.
Pacht ER
Crit Care Med; 2006 Sep; 34(9):2492-3. PubMed ID: 16921322
[No Abstract] [Full Text] [Related]
24. Lipids in critical care medicine.
Ott J; Hiesgen C; Mayer K
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):267-73. PubMed ID: 21546231
[TBL] [Abstract][Full Text] [Related]
25. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia.
Agostoni C; Scaglioni S; Bonvissuto M; Bruzzese MG; Giovannini M; Riva E
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):111-5. PubMed ID: 11237478
[TBL] [Abstract][Full Text] [Related]
26. Modified EN support for patients with acute respiratory distress syndrome.
Dickerson RN
JPEN J Parenter Enteral Nutr; 2008; 32(6):671-2. PubMed ID: 18974252
[No Abstract] [Full Text] [Related]
27. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
[TBL] [Abstract][Full Text] [Related]
28. Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children.
Covar R; Gleason M; Macomber B; Stewart L; Szefler P; Engelhardt K; Murphy J; Liu A; Wood S; DeMichele S; Gelfand EW; Szefler SJ
Clin Exp Allergy; 2010 Aug; 40(8):1163-74. PubMed ID: 20545703
[TBL] [Abstract][Full Text] [Related]
29. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial.
Jung JY; Kwon HH; Hong JS; Yoon JY; Park MS; Jang MY; Suh DH
Acta Derm Venereol; 2014 Sep; 94(5):521-5. PubMed ID: 24553997
[TBL] [Abstract][Full Text] [Related]
30. Omega-3 fatty acids in rheumatoid arthritis.
Kremer JM
Del Med J; 1988 Nov; 60(11):679-81. PubMed ID: 2852607
[No Abstract] [Full Text] [Related]
31. In Response.
Dasarathy S; Dasarathy J; Khiyami A; Yerian L; McCullough AJ
J Clin Gastroenterol; 2016 Feb; 50(2):181. PubMed ID: 26583270
[No Abstract] [Full Text] [Related]
32. Prospectives on n-3 fatty acids in medical research.
Dyerberg J; Nordøy A
J Intern Med Suppl; 1989; 731():237-8. PubMed ID: 2539834
[No Abstract] [Full Text] [Related]
33. [Clinico-pharmacological effects of eicosapentaenoic and docosahexaenoic (omega-3) acids in the treatment of ischemic heart disease and prevention of sudden cardiac death from position of evidence based medicine].
Pchelintsev MV
Kardiologiia; 2010; 50(3):74-8. PubMed ID: 20459410
[No Abstract] [Full Text] [Related]
34. [The pharmacodynamics of eicosapentaenoic and docosahexaenoic acids].
Krylov IuF; Liubimov IB; Muliar AG
Farmakol Toksikol; 1991; 54(5):67-72. PubMed ID: 1839286
[No Abstract] [Full Text] [Related]
35. [EPA and DHA ethyl esters: potential mechanisms of antischemic action].
Cerbone AM; Piemontino U; Coppola A; Albisinni R; Cimino E; Di Minno G
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):743-4. PubMed ID: 12497815
[No Abstract] [Full Text] [Related]
36. [The membrane-protective action of a new preparation of n-3 polyenic acids in the adrenaline-damaged myocardium].
Kresiun VI; Minakov OI; Hodziieva IN; Tyshchenko OV; Kravchenko LS; Dzenkevych IO
Lik Sprava; 1996; (3-4):49-52. PubMed ID: 9035880
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acids in the treatment of depression.
Harv Ment Health Lett; 2001 Oct; 18(4):4-5. PubMed ID: 11770480
[No Abstract] [Full Text] [Related]
38. The fish oil story--back to Greenland?
Gajos G
Cardiology; 2011; 118(4):245-7. PubMed ID: 21757896
[No Abstract] [Full Text] [Related]
39. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
Barden A; O'Callaghan N; Burke V; Mas E; Beilin LJ; Fenech M; Irish AB; Watts GF; Puddey IB; Huang RC; Mori TA
Nutrients; 2016 Mar; 8(3):175. PubMed ID: 27007392
[TBL] [Abstract][Full Text] [Related]
40. Autonomic function, omega-3, and cardiovascular risk.
Abuissa H; O'Keefe JH; Harris W; Lavie CJ
Chest; 2005 Apr; 127(4):1088-91. PubMed ID: 15821175
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
